Partner Sirolimus-eluting Coronary Stent System

Features The successful delivery of efficacy and safety through the combination of a proven drug and a reliable polymer A Proven Drug Maximum DES Efficacy 1. Over 5 years of proven clinical application experience 2. Effective anti-restenosis and anti-inlammatory propertiesA Reliable Polymer Long-term safety 1. Advanced polymer-coating technology provides optimally controlled release of sirolimus that efficaciously inhibits intimal hyperplasia and restenosis. 2. PBMA/PEVA coating is a widely used biocompatible coating that provides an ideally controlled drug release 3. Only 6 µm thickness of polymer, thinner coating increases deliverability of stentAdvanced Stent Design High confidence deliveryProprietary DOUBLE-HELIX stent structure is engineered for outstanding flexibility and conformability. Optimal thickness of stent strut provides favorable balance between radial strength and deliverability The unique 36 mm length makes it easy to achieve full coverage of long lesion.